Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Apr 15;15(4):e0231264. doi: 10.1371/journal.pone.0231264

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Wu et al

This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PMC Copyright notice

Fig 4 — 4A. Incidence of acute kidney injury after contrast-enhanced computed tomography (CCT) divided by different serum levels of total bilirubin in patients with cirrhosis. No statistical significance was noticed between the groups of ≤ 1.2 mg/dl and 1.3–2.0 mg/dl of serum bilirubin (6.6 vs. 7.2%). Differences are statistically significant between groups of ≤ 1.2 mg/dl and > 2.0 mg/dl of serum bilirubin (6.6 vs. 20.5%, p<0.001), and between 1.3–2.0 mg/dl and >2.0 mg/dl of serum bilirubin (7.2 vs. 20.5%, p<0.001). 4B. Incidence of acute kidney injury after contrast-enhanced computed tomography (CCT) divided by different serum levels of total bilirubin in patients with hepatoma. No statistical significance was noticed between the groups of ≤1.2 mg/dl and 1.3–2.0 mg/dl of serum bilirubin (6.4% vs. 9.2%). Differences are statistically significant between groups of ≤ 1.2 mg/dl and > 2.0 mg/dl of serum bilirubin (6.4 vs. 20.9%, p<0.001), and between 1.3–2.0 mg/dl and >2.0 mg/dl of serum bilirubin (9.2 vs. 20.9%, p<0.001). 4C. Incidence of acute kidney injury after contrast-enhanced computed tomography (CCT) divided by different serum levels of total bilirubin in patients without hepatoma or cirrhosis. No statistical significance was noticed between the groups of ≤1.2 mg/dl and 1.3–2.0 mg/dl of serum bilirubin (8.1% vs. 9.6%). Differences are statistically significant between groups of ≤ 1.2 mg/dl and > 2.0 mg/dl of serum bilirubin (8.1 vs. 13.4%, p<0.001), and between 1.3–2.0 mg/dl and >2.0 mg/dl of serum bilirubin (9.6 vs. 13.4%, p<0.001).